Back to search
FDAFDA · Food and drugs·Recall number Z-1440-2017

Eclipse Hypodermic Needle

Published March 22, 2017 · Recall initiated: December 20, 2016

Summary

FDA records medical device Class II recall Z-1440-2017, published March 22, 2017 and initiated December 20, 2016. Recalling firm: Becton Dickinson & Company; Status: Terminated; Reported quantity: 263 mm units. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton Dickinson & Company
Distributor
US Nationwide
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Eclipse Hypodermic Needle recalled?

Yes. FDA published recall Z-1440-2017 on March 22, 2017. Reported hazard: BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries.

What should I do if I have this product?

Voluntary: Firm initiated · Letter